Blau Farmaceutical S.A

Blau is a leading pharmaceutical company in the institutional segment of the market where it operates, as well as a biotechnology pioneer among Brazilian companies, with its own portfolio of high-complexity drugs with a focus on its segments of operation in the industry, such as immunology, hematology, oncology, nephrology, infectious diseases, anesthesiology, and others.

It has a continental footprint and is present in seven South American countries – Argentina, Brazil, Chile, Colombia, Ecuador, Peru and Uruguay – and in the USA.